86 related articles for article (PubMed ID: 20628968)
1. [Coagulation factors as potential tumour markers in patients with head and neck carcinomas?].
Greve J; Schuler PJ; Bas M; Adamzik M; Brandau S; Arweiler-Harbeck D; Lang S; Hoffmann TK
Laryngorhinootologie; 2010 Oct; 89(10):612-5. PubMed ID: 20628968
[TBL] [Abstract][Full Text] [Related]
2. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
Gotschuli A; Anderhuber W; Danninger R; Habermann W
Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
[TBL] [Abstract][Full Text] [Related]
4. [Use of MR-controlled laser-induced thermotherapy in recurrent squamous epithelial carcinoma of the head-neck area].
Bockmühl U; Knöbber D; Vogl T; Mack M
Laryngorhinootologie; 1996 Oct; 75(10):597-601. PubMed ID: 9035663
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in primary radiochemo-therapy in advanced head and neck tumours with specific reference to the tumour cell cycle components and tumour oxygenation].
Dietz A
Laryngorhinootologie; 2002 Jan; 81(1):63-4. PubMed ID: 11845405
[No Abstract] [Full Text] [Related]
6. [Status of essential trace elements in untreated carcinomas of the head and neck].
Büntzel J; Glatzel M; Micke O; Fröhlich D
Laryngorhinootologie; 2003 Aug; 82(8):573-7. PubMed ID: 12915990
[TBL] [Abstract][Full Text] [Related]
7. [Indications and risks of manual lymph drainage in head-neck tumors].
Preisler VK; Hagen R; Hoppe F
Laryngorhinootologie; 1998 Apr; 77(4):207-12. PubMed ID: 9592754
[TBL] [Abstract][Full Text] [Related]
8. [Thrombin-antithrombin III complex concentrations in patients with invasive cervix cancer].
Reinthaller A; Tatra G
Gynakol Rundsch; 1990; 30 Suppl 1():121-3. PubMed ID: 2079245
[No Abstract] [Full Text] [Related]
9. [Intralesional therapy with natural interferon-beta in refractory squamous epithelial cancers of the ENT area].
Steuer MK; Matthias R; Schulze C; Brusis T
Laryngorhinootologie; 1992 Dec; 71(12):618-25. PubMed ID: 1283513
[TBL] [Abstract][Full Text] [Related]
10. [Development, current status and perspectives of tumor therapy in oromandibulofacial surgery--a determination of the current status].
Hausamen JE; Eckardt A; Schmelzeisen R
Fortschr Kiefer Gesichtschir; 1994; 39():5-12. PubMed ID: 8088670
[No Abstract] [Full Text] [Related]
11. [CEA studies in squamous cell carcinomas of the head and neck].
Schröder M; Meyer T
HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
13. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
Nagayama M; Tachibana A; Hayakawa H; Sato A
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
[TBL] [Abstract][Full Text] [Related]
14. Head and neck cancer: the importance of oxygen.
Terris DJ
Laryngoscope; 2000 May; 110(5 Pt 1):697-707. PubMed ID: 10807350
[TBL] [Abstract][Full Text] [Related]
15. [Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Di Martino E; Hausmann R; Krombach GA; Nowak B; Tietze L; Gagel B; Zimny M; Westhofen M
Laryngorhinootologie; 2002 Dec; 81(12):866-74. PubMed ID: 12486624
[TBL] [Abstract][Full Text] [Related]
16. [Biology and relevance of stem cells in squamous head and neck cancer: latest insights and review of literature].
Oker N; Kaufmann AM; Albers AE
Laryngorhinootologie; 2012 May; 91(5):326-32; quiz 333-4. PubMed ID: 22517584
[TBL] [Abstract][Full Text] [Related]
17. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
[TBL] [Abstract][Full Text] [Related]
18. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?
Guney K; Yoldas B; Ozbilim G; Derin AT; Sarihan S; Balkan E
Saudi Med J; 2007 Feb; 28(2):216-20. PubMed ID: 17268699
[TBL] [Abstract][Full Text] [Related]
19. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.
Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Forteza J; Fraga M
J Oral Pathol Med; 2010 Aug; 39(7):571-8. PubMed ID: 20202087
[TBL] [Abstract][Full Text] [Related]
20. Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?
Dequanter D; Lothaire P; Awada A; Lalami Y; Hien Nguyen T; Lemort M; Vandevelde L; Andry G
Acta Otolaryngol; 2006 Dec; 126(11):1225-8. PubMed ID: 17050318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
